Objectives: Rasagiline, a drug for Parkinson’s disease is metabolized by CYP1A2 enzyme. The objective of the study was to investigate the influence of cytochrome P450 1A2 variants and smoking status of healthy individuals on the pharmacokinetics of rasagiline. Methods: A comparative, open label, interventional, single oral dose, pharmacokinetic study was performed on 108 healthy volunteers in UHS & UVAS, Lahore. Data collection was initiated in June 2016 and ended in January 2018. It was divided in three phases with 1, 2 and 5mg of rasagiline given to a group of 36 volunteers in each phase. Volunteers were sub-divided into six groups of AA smokers, AA non-smokers, AC smokers, AC non-smokers, CC smokers & CC non-smokers on the basis of genotyping and smoking status. Serial blood sampling was performed at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8 & 12 hours after administration of rasagiline tablets. Plasma concentrations were determined using High Performance Liquid Chromatography (HPLC) method. Pharmacokinetic (PK) parameters were calculated using software (APO) pharmacological analysis. Results: Analysis of variance (ANOVA) showed significant difference between AA and CC groups. Multiple group comparison with post hoc Tukey’s revealed that AA-smokers had significantly less tmax (p<0.001), t1/2 (p<0.012), AUC (p<0.008) and highest Cl (p<0.001) as compared to CC-smokers. The trend was same across all three doses. Conclusion: The study concludes that the systemic metabolism of rasagiline is significantly increased in CYP1A2*AA variants while smoking status did not show consistent difference in PK parameters. Registered Trial: ISRCTN68198254 doi: https://doi.org/10.12669/pjms.38.3.4940 How to cite this:Bilal R, Ahmad NS, Zaffar S, Mazhar MU, Siddiqui WA, Tariq S. Rasagiline Pharmacokinetics in CYP1A2 Variant Healthy Smokers & Non-smokers in Different Doses. Pak J Med Sci. 2022;38(3):---------. doi: https://doi.org/10.12669/pjms.38.3.4940 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction Astragalus species have been widely used in Chinese herbal medicine to treat gastrointestinal and inflammatory disorders. This study was conducted to evaluate the efficacy of Astragalus sarcocolla (ASE) and to rationalize its medicinal use as an antispasmodic drug for the treatment of spasmodic gastrointestinal and inflammatory disorders associated with increased intestinal motility. Methods The ethanolic extract of ASE was studied to examine its antispasmodic effect on the isolated rabbit ileum preparations, and the contractions were recorded on PowerLab (ADInstruments, Sydney, Australia). Results ASE was able to inhibit spontaneous ileum contractions. It also completely inhibited K + (25 mM)-induced contractions but was unable to inhibit high K + (80 mM)-induced sustained contractions. Pretreatment of the tissue with glibenclamide, a potassium channel blocker, caused a rightward shift of the dose-response curve when stimulated with K + (25 mM) in the presence of an increasing concentration of the extract. Verapamil at very low doses inhibited both the 25 mM and 80 mM K +-induced contractions. Conclusion The results of our study demonstrated the spasmolytic activity of ASE with the potential mechanism of activation of K + ATP, which provides a strong basis for its medicinal use in motility and inflammatory disorders of the intestine.
Background: Moringa oleifera is a plant rich in bioactive compounds, including flavonoids, polyphenols, and alkaloids, which have been shown to have numerous health benefits. In recent years, several studies have investigated the potential of Moringa oleifera in the treatment ofhypertension and diseases of vascular dysfunction. Aim: To observe the effect of M. oleifera leaf extract on contractility of aortic tissue of mice, in vitro. Methods: An animal-based in-vitro experimental study was carried out in Pharmacology Department of CMH Lahore Medical College and Institute of Dentistry from February 2022 to March 2023. Mice were euthanized with ketamine. Aortic tissue was dissected and mounted in the organ bath. For evaluation of vasodilatory effect, cumulative dose-response curve of M. oleifera leaf extract was obtained using increasing doses of the extract against1 µM adrenaline and 80 mM KCl, in group I and group II, respectively.Response was obtained through Powe rLab (AD Instruments, Australia). Results: A consistent decrease was recorded against adrenaline and KCl-induced contractions in aorta, resulting in vasodilation. IC50 was 0.068 mg and 0.161 mg, in group I and II, respectively. Difference between IC50 of both groups was statistically significant (p-value = 0.0008). Conclusion: Leaf extract of Moringa oleifera exerts smooth muscle relaxant effectin blood vessels, most likely through inhibition of calcium influx, mediated through Gq-signalling pathway as well as depolarization-dependent voltage operated calcium channels. Keywords: Moringa oleifera, dose-response relationship, trachea, aorta, calcium channels
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.